Phase I Trial of Pbi-shRNA EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Bi shRNAEWS-FLI-Type-1-LPX (Primary)
- Indications Ewing's sarcoma
- Focus Adverse reactions
- Sponsors Gradalis; Strike Bio
- 16 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2016 Status changed from not yet recruiting to recruiting.
- 22 Jul 2016 Planned primary completion date changed from 1 May 2018 to 1 Sep 2018.